Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Etretinate was effective for certain skin conditions, but caused side effects like chapped lips, dry mucous membranes, and hair loss.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Suplatast tosilate successfully treated a woman's systemic sclerosis symptoms.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Baricitinib is effective and safe for treating severe alopecia areata.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

The new gel for psoriasis is effective, stable, and easy to apply.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.